Lanreotide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Lanreotide and local guidelines before prescribing.

Somatostatin analogue

Mechanism

Long-acting somatostatin analogue.

Uses

Acromegaly, neuroendocrine tumours.

Dosing

Side effects

Diarrhoea, gallstones, injection-site reactions, bradycardia.

Interactions

Ciclosporin levels fall.

Contraindications and cautions

Hypersensitivity

Monitoring

IGF-1, glucose

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in renal and hepatic impairment

Overdose and reversal

Supportive

Special advice

Monitor glucose and gallbladder.

More from the textbook: uses, cautions and other points
Where it is discussed in the book